Controversies in the systemic management of patients with evidence of biochemical failure following radical prostatectomy.

@article{Dreicer2002ControversiesIT,
  title={Controversies in the systemic management of patients with evidence of biochemical failure following radical prostatectomy.},
  author={Robert Dreicer},
  journal={Cancer treatment reviews},
  year={2002},
  volume={28 4},
  pages={189-94}
}
The management of patients with evidence of a detectable prostate-specific antigen (PSA) following prostatectomy is an increasingly common and difficult issue for patients and clinicians alike. In the setting in which biochemical failure is believed representative of early systemic failure, therapeutic options primarily involve the use of hormonal therapy… CONTINUE READING